English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNew research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.
Tag: Medical Conference
Study Finds Most Fetal Congenital Heart Block Screening Fails to Meet Guidelines
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that most echocardiography screening for fetal congenital heart block in anti-Ro- and anti-La-positive pregnancies did not follow recommended guidelines in one academic medical center.
Study Finds Spine Disease Is More Common in Chronic Recurrent Multifocal Osteomyelitis than Previously Thought
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as many as 10-35% of patients and is asymptomatic in one-third.
Study Finds Holding Methotrexate for One Week after Flu Vaccine May Be as Effective as a Two-Week Hold
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, showed that discontinuing methotrexate for 1 week after seasonal influenza vaccination provided the same seroprotection as a 2 week discontinuation period in patients with RA.
Study Finds Combination Therapy Does Little to Slow Spine Damage in Radiographic Axial Spondyloarthritis Patients
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that combining a nonsteroidal anti-inflammatory drug and TNF inhibitor did not significantly slow radiographic spinal progression in radiographic axial spondyloarthritis patients.
Study Finds No Increased Cancer Risk in Rheumatology Patients with History of Malignancy Taking DMARDS and TNF Inhibitors
New research presented this week at ACR Convergence, the organization’s annual meeting, found no significant difference in cancer risk in patients with rheumatic disease & a history of malignancy taking biologic or targeted synthetic DMARDs compared to those treated with TNF inhibitors.
Study Finds Opioids Double Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).
Study Links Lower Hydroxychloroquine Dose to More Hospitalizations for Systemic Lupus Erythematosus Flares
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual scientific meeting, found that the recommended weight-based or non-weight-based dose of hydroxychloroquine led to more hospitalizations for flares among patients with systemic lupus erythematosus
Primary Care Provider Training Program Improves RA Care on Navajo Nation
Research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, described a novel program that offers rheumatoid arthritis (RA) training to primary care providers in the Navajo Nation, the largest American Indian reservation in the United States.
Study Finds Early TNF Inhibitor Treatment Is Associated with Higher Heart Disease Risk in Ankylosing Spondylitis Patients — with Caveats
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that early initiation of tumor necrosis factor (TNF) inhibitors was associated with higher risk of heart disease in patients diagnosed with ankylosing spondylitis.
Study Finds More Polyarticular JIA Patients Achieve Clinical Remission with Combined Conventional and Biologic DMARDs
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, demonstrated that polyarticular JIA patients were more likely to achieve clinical remission with a combination of conventional and biologic DMARDs compared with other treatment plans.
Study Finds NSAID Use and Age May Delay Conception in Spondyloarthritis Patients
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and older age were associated with longer time to conception in spondyloarthritis patients.
New Analysis Finds Belimumab Improves Cutaneous Lupus Erythematosus in Patients with or without SLE
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not patients also had systemic lupus erythematosus (SLE or lupus).
Study Finds Lower Risk of Severe Infection and Hospitalization with Belimumab Compared to Oral Immunosuppressants
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the biologic B-cell inhibitor belimumab was associated with a lower risk of severe infections and hospitalizations compared to nonbiologic immunosuppressants.
Artificial Intelligence Shows Potential for Accurate Assessment of Nailfold Changes in Systemic Sclerosis Patients
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that the Vision Transformer, an open-source computer vision algorithm, could detect changes in nailfold capillaroscopy images from systemic sclerosis patients.
Researchers Develop a Risk Score to Help Detect ILD in Systemic Sclerosis Patients
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, described a first-of-its-kind validated tool to screen for systemic sclerosis-associated interstitial lung disease.
Holding Mycophenolate Mofetil for 10 Days or More May Improve COVID-19 Vaccine Response
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated that withholding mycophenolate mofetil for 10 days significantly increased antibody response after 2 doses of COVID-19 vaccine, without a significant increase in flares.
Preterm Birth More Common in Unvaccinated Pregnant Patients with Rheumatic Disease and COVID-19
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found a greater number of preterm births in unvaccinated versus fully vaccinated pregnant patients with rheumatic disease and COVID-19.
Desai Sethi Urology Institute Draws Renowned Urologists, Researchers to Inaugural ‘Urology on the Beach’ Meeting, January 2023
The Desai Sethi Urology Institute at the University of Miami Miller School of Medicine will be hosting urology clinicians and scientists from today’s most prominent academic centers at the institute’s inaugural in-person “Urology on the Beach” meeting, January 13 to 15, 2023, at the Fontainebleau Hotel in Miami Beach.
Press Registration Now Open for ACR Convergence 2022
The American College of Rheumatology (ACR) is providing complimentary registration to journalists wishing to write about studies presented at ACR Convergence 2022, the ACR’s annual meeting taking place Nov. 10 – 14.
Race, Age, Sex and Language Affected Telemedicine Use by Rheumatology Clinic Patients During COVID-19 Pandemic
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows a significant lack of fairness among telemedicine and electronic patient portals used by rheumatology clinic patients based on their race, age, sex and English language proficiency.
Patients taking Rituximab Could Benefit from Third COVID-19 Vaccine Dose
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows patients using rituximab were able to produce antibodies against COVID-19 after receiving a third vaccine dose, even if there was no development of the antibody after the first two.
Nearly One Third of Lupus Patients in One Study Had Low Responses to COVID-19 Vaccines
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that nearly 30% of patients with lupus in a multi-ethnic and multi-racial study had a low response to the new COVID-19 vaccines.
Black People with Systemic Sclerosis May Have More Severe Disease, Worse Prognosis
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that Black people living with systemic sclerosis may have more severe disease and worse prognosis than patients in other racial or ethnic groups.
Study Finds Cycling JAK Inhibitors Effective Option for Patients with Difficult-to-Treat RA
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with JAK inhibitor can achieve success either cycling to other JAKi or switching to a biologic drug.
Pregnant Women with Takayasu’s Arteritis and Their Babies at High Risk for Serious Complications
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that pregnant women with Takayasu’s arteritis appear to have a high prevalence of serious maternal and fetal adverse outcomes
Ultra-Low Dose Rituximab Controls Disease Activity for Most RA Patients in New Study
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows the majority of rheumatoid arthritis patients on an ultra-low dose of rituximab maintained low disease activity for up to 4 years, and rarely needed to switch to other biologic drugs.
Virtual Exercise Effective for People with Arthritis and Helps Them Stay Socially Connected Too
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that a virtual exercise program can be safe for people with musculoskeletal conditions, improved their health outcomes, and helped them feel more socially connected.
Higher Doses and Longer Use of Hydroxychloroquine Increase Risk of Severe Eye Complication
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be risk factors for retinopathy in people using hydroxychloroquine for rheumatoid arthritis.
Groundbreaking Study Reveals Clues to Predict Mortality in Rare VEXAS Syndrome
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows a relationship between genotype, bone marrow failure and survival in patients with the rare autoinflammatory disease VEXAS syndrome, which was only identified in 2020.
Hydroxychloroquine, Mainstay Lupus Treatment, Not Associated With Serious Cardiac Complication
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that hydroxychloroquine does not appear to be associated with QTc interval prolongation.
Platelet Inhibitors May Reduce Digital Ulcers, a Common, Painful Systemic Sclerosis Complication
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that use of platelet inhibitors could be associated with a reduction in the occurrence of digital ulcers in people with systemic sclerosis.
Study Finds COVID-19 Vaccine Not Associated with Severe Disease Flare in Patients with Rheumatic Diseases
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.
Biologics Now Most Common Treatment for Children with Systemic JIA, and Many Have Excellent Results
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that biologics were the most common initial treatment prescribed to treat systemic juvenile idiopathic arthritis patients in one major registry.
Press Registration Now Open for ACR Convergence 2021
The American College of Rheumatology (ACR) is providing complimentary registration to journalists wishing to write about studies presented at ACR Convergence 2021, the ACR’s annual meeting taking place Nov. 1 – 10.
Apply today for press credentials to cover the virtual American College of Surgeons Clinical Congress 2021
The virtual American College of Surgeons (ACS) Clinical Congress 2021 will convene October 23-27, offering surgeons and guest clinicians both live and on-demand sessions. The conference will offer the finest in continuing education for surgeons across all specialties and throughout all stages of their careers.
Award-Winning Journalist and CDC Principal Investigator to Serve as ACR Convergence 2021 Keynote Speaker
Convergence 2021, the annual meeting of the American College of Rheumatology (ACR), returns to a virtual meeting platform Nov. 1 – 10. This year’s meeting will include presentations from over 320 clinicians, researchers and health experts, including this year’s keynote speaker, Dr. Seema Yasmin.
University of Miami Hearing Professionals Present Latest Research at American Cochlear Implant Alliance Conference
From the impact of COVID-19 on parents, to speech differences between English- and Spanish-learners, and advanced ear surgery techniques, University of Miami Miller School of Medicine hearing professionals presented their latest studies at CI2021, the annual conference of the American Cochlear Implant (ACI) Alliance, from April 28 to May 1.
NCCN 2020 Annual Conference to Examine Advances in Cancer Care and Emerging Issues in Oncology
Cancer care providers will gather in Orlando on March 20-22 for the National Comprehensive Cancer Network® (NCCN®) 2020 Annual Conference: Celebrating 25 Years of NCCN. The three-day, in-person conference features more than 30 educational sessions on state-of-the-art practices in cancer care.
AAHCM Shares Success from 2019 Annual Meeting
With over 450 attendees, this meeting provides health care professionals with training and education on the unique aspects of providing home-based medical care as well as an understanding of how to sustain these medical practices.
Congress of Neurological Surgeons Hosts 2019 Annual Meeting in San Francisco, October 19–23
Schaumburg, Illinois, August 21, 2019 — The Congress of Neurological Surgeons (CNS) is proud to host its 67th Annual Meeting in San Francisco, California, October 19–23. Each year, thousands of neurosurgeons, advanced practice providers, health care advocates, and other professionals from around the world gather to celebrate and learn about the advances are being made in the field of neurosurgery.